COVID-19: Intensive care management
Revue Medicale Suisse
; 16(691):863-868, 2020.
Article
in French
| EMBASE | ID: covidwho-1870384
ABSTRACT
The SARS-coronavirus 2 disease initially reported in December 2019 in China (COVID-19) represents a major challenge for intensive care medicine, due to the high number of ICU admission and the prolonged stay for many patients. Up to 5% of COVID-19 infected patients develop severe acute hypoxemic respiratory failure requiring invasive mechanical ventilation as supportive treatment. Apart from early antiviral and anti-inflammatory treatment, the management of COVID-19 patients is mainly applying protective mechanical ventilation, to support the injured lungs. However recently acquired data and clinical experience suggest that COVID-19-related ARDS presents some specificities that will be summarized in the present article.
acute hypoxemic respiratory failure; adult; adult respiratory distress syndrome; article; artificial ventilation; China; coronavirus disease 2019; drug therapy; human; intensive care; intensive care medicine; invasive ventilation; nonhuman; Severe acute respiratory syndrome coronavirus 2; antivirus agent
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
French
Journal:
Revue Medicale Suisse
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS